Thomas Gardner

Title: Innovations by Thomas Gardner in Targeting Cancer Cells

Introduction

Thomas Gardner is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his research and development of targeted therapies. His work focuses on creating systems that can effectively target specific cancer markers, which is crucial for improving treatment outcomes.

Latest Patents

Thomas Gardner holds a patent for "Systems targeting PSMA and CA9." This patent includes antibodies and chimeric priming receptors that bind to PSMA, as well as antibodies and chimeric antigen receptors that bind to CA9. The patent also describes systems of chimeric priming receptors that bind PSMA and chimeric antigen receptors that bind CA9, along with cells expressing these systems and methods of use thereof. He has 1 patent to his name.

Career Highlights

Currently, Thomas Gardner is employed at Arsenal Biosciences, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing innovative solutions that can potentially change the landscape of cancer treatment.

Collaborations

Thomas collaborates with talented individuals in his field, including Angela Boroughs and Levi Gray-Rupp. These partnerships enhance the research and development process, leading to more effective therapeutic solutions.

Conclusion

Thomas Gardner's contributions to cancer treatment through his innovative patent and work at Arsenal Biosciences, Inc. highlight the importance of targeted therapies in modern medicine. His ongoing research promises to make a significant impact in the fight against cancer.